RECOVERY ADVOCATE LAUNCHES A GUIDE FOR LIFE AFTER ADDICTION
November 21, 2019 09:59 ET
|
Reach Out Recovery
Sarasota, Florida, Nov. 21, 2019 (GLOBE NEWSWIRE) -- In commemoration of her 20-year recovery journey, award-winning documentary filmmaker and founder of Reach Out Recovery Lindsey Glass is...
Emerald Health Therapeutics’ Licensed Endo Product Wins Taste For Life’s 2019 Essentials Supplement Award in the U.S.
March 07, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its joint venture partner’s, (Emerald Health Bioceuticals or...
New coming-of-age novel takes readers back to the age of Fats Domino
January 08, 2019 08:38 ET
|
Palmetto Publishing Group
Charleston, SC, Jan. 08, 2019 (GLOBE NEWSWIRE) -- I Want to Walk You Home by Ron Thomas Genre: Coming-of-age Price: $12.99 ISBN: 978-1-64111-198-0 283 pages, paperback Publication Date:...
Rhizen Pharmaceuticals S.A. receives FDA orphan-drug designation for Tenalisib (RP6530) for treatment of cutaneous T-cell lymphoma (CTCL)
April 09, 2018 07:00 ET
|
Rhizen Pharmaceuticals SA
La Chaux-de-Fonds, Switzerland, April 09, 2018 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation...
Novel treatment of hemophilia: OMRF enters license agreement with Shanghai RAAS Blood Products
February 13, 2018 15:02 ET
|
Oklahoma Medical Research Foundation
OKLAHOMA CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- The Oklahoma Medical Research Foundation has entered a license agreement with Shanghai RAAS Blood Products Co., Ltd. Under the agreement, Shanghai...
Cantabio Pharmaceuticals Announces the Development of Small Molecule Chaperones of the Abeta Peptide for the Treatment of Alzheimer's Disease in Collaboration with NovAliX
April 12, 2016 12:00 ET
|
Cantabio Pharmaceuticals Inc.
PALO ALTO, Calif., April 12, 2016 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals Inc. (OTCQB:CTBO) announced today a new preclinical therapeutic program for Alzheimer’s Disease which it is...
Chinelo Okparanta's Highly Anticipated Debut Novel "Under the Udala Trees" Launches with an Event at Housing Works Bookstore Cafe
September 22, 2015 12:05 ET
|
Southern New Hampshire University MFA and Creative Writing
MANCHESTER, N.H., Sept. 22, 2015 (GLOBE NEWSWIRE) -- Southern New Hampshire University's low-residency MFA in Fiction and Nonfiction program would like to congratulate Chinelo Okparanta on the launch...
Rhizen Pharmaceuticals S.A. to present preclinical data of RP6530 (dual PI3K delta/gamma inhibitor) in Multiple Myeloma
November 18, 2014 07:00 ET
|
Rhizen Pharmaceuticals SA
La Chaux-de-Fonds, Switzerland, Nov. 18, 2014 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A. announces a poster presentation for
RP6530, a novel dual PI3K delta/gamma inhibitor in Multiple
Myeloma.
...
First Novel Written, Honored, Published
July 15, 2014 11:01 ET
|
Southern New Hampshire University MFA and Creative Writing
MANCHESTER, N.H., July 15, 2014 (GLOBE NEWSWIRE) -- In 2008 Ben Schwartz—a young New Hampshire English and special education teacher—decided it was time to get that first novel written. He...
The Secret to Her Artistry
June 12, 2014 13:32 ET
|
Southern New Hampshire University MFA and Creative Writing
Novelist Ann Garvin, author of "The Dog Year," was well along in a very different career. Then she discovered the narrative power of empathy.
MANCHESTER, N.H., June 12, 2014 (GLOBE NEWSWIRE) --...